Preparation and evaluation of zidovudine-loaded sustained-release microspheres .2. Optimization of multiple response variables

被引:34
作者
AbuIzza, K [1 ]
GarciaContreras, L [1 ]
Lu, DR [1 ]
机构
[1] UNIV GEORGIA,COLL PHARM,DEPT PHARMACEUT,ATHENS,GA 30602
关键词
D O I
10.1021/js960021k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The formulation of zidovudine-loaded (AZT-loaded) sustained-release microspheres was prepared and optimized using response surface methodology. The objective was to use this statistical procedure to obtain a formulation with optimized overall properties. The effect of formulation variables (emulsifier concentration, drug to polymer ratio, and composition of the internal phase of the emulsion) on a number of response variables was systemically investigated. The response variables were t(85), entrapment efficiency, yield, and percentage of loose surface crystals. A desirability function that combines these four response variables was constructed. A second-order polynomial equation was fitted to the data, and the resulting equation was used to predict the responses in the optimal region. All the investigated response variables were found to be highly dependent on the formulation variables, with strong interactions observed between the formulation variables. it was found that optimum overall desirability of AZT microspheres can be obtained at low levels of SDS and ethyl acetate concentrations and at intermediate levels of drug to polymer ratio. An optimized formulation was prepared under these experimental conditions and evaluated for individual responses and overall desirability. The experimental values of the response variables highly agreed with the predicted values.
引用
收藏
页码:572 / 576
页数:5
相关论文
共 13 条
  • [1] ABUIZZA KA, 1996, J PHARM SCI, V85, P144
  • [2] [Anonymous], 1986, PRACTICAL EXPT DESIG
  • [3] THE PHARMACOKINETICS OF ZIDOVUDINE ADMINISTERED BY CONTINUOUS INFUSION IN CHILDREN
    BALIS, FM
    PIZZO, PA
    MURPHY, RF
    EDDY, J
    JAROSINSKI, PF
    FALLOON, J
    BRODER, S
    POPLACK, DG
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (04) : 279 - 285
  • [4] DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968
  • [5] SERUM, CEREBROSPINAL-FLUID, AND BRAIN CONCENTRATIONS OF A NEW ZIDOVUDINE FORMULATION FOLLOWING CHRONIC ADMINISTRATION VIA AN IMPLANTABLE PUMP IN DOGS
    GALLO, JM
    SANZGIRI, Y
    HOWERTH, EW
    FINCO, TS
    WILSON, J
    JOHNSTON, J
    TACKETT, R
    BUDSBERG, SC
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (01) : 11 - 15
  • [6] Harrington E. C., 1965, IND QUALITY CONTROL, V21, P494, DOI DOI 10.1128/AM.13.3.494-495.1965
  • [7] OPTIMIZED FORMULATION OF MAGNETIC CHITOSAN MICROSPHERES CONTAINING THE ANTICANCER AGENT, OXANTRAZOLE
    HASSAN, EE
    PARISH, RC
    GALLO, JM
    [J]. PHARMACEUTICAL RESEARCH, 1992, 9 (03) : 390 - 397
  • [8] Khui A., 1987, RESPONSE SURFACES DE
  • [9] Lind E.E., 1960, CHEM ENG PROGR, V56, P62
  • [10] LU DR, UNPUB DRUG DEV IND P